Antibody and Cell-mediated Immune Responses
Showing 1 - 25 of >10,000
IsThird Dose of MMRV Vaccine Beneficial for Adult Population in
Not yet recruiting
- Vaccination Failure
- Vaccine Response Impaired
- Serology for antibody levels - Baseline
- +3 more
- (no location specified)
Jun 26, 2023
Immune-mediated Diseases
Recruiting
- Primary Immunodeficiency
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 10, 2023
Rabies Trial in Bangkok (rabies vaccine)
Recruiting
- Rabies
- rabies vaccine
-
Bangkok, ThailandQueen Saovabha Memorial Institute, Thai Red Cross Society
Apr 28, 2022
Antibody Mediated Processes After Kidney Transplantation
Recruiting
- Kidney Transplant Failure and Rejection
- AlloSure ddcfDNA assay
- +3 more
-
Madison, WisconsinUniversity of Wisconsin - Madison
Aug 16, 2022
COVID-19 Vaccination in Multiple Sclerosis Treated With Immune
Active, not recruiting
- Multiple Sclerosis
- Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus
-
Portland, OregonProvidence Neurological Specialties West
Sep 1, 2022
Kidney Transplant Rejection, Antibody-mediated Rejection, Kidney Transplant Failure Trial in Berlin (Kidney allograft biopsy
Active, not recruiting
- Kidney Transplant Rejection
- +2 more
- Kidney allograft biopsy depending on donor-derived cell-free DNA levels
-
Berlin, GermanyCharité-Universitätsmedizin
Jul 22, 2022
Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Immune Mediated Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)
Not yet recruiting
- Stage IV NSCLC
- Poly ICLC
- IVIG
-
Houston, TexasMichael E. DeBakey VA Medical Center, Houston, TX
Sep 28, 2023
Dengue Fever Trial in Peoria, Portland (Takeda's Tetravalent Dengue Vaccine Candidate (TDV))
Completed
- Dengue Fever
- Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
-
Peoria, Illinois
- +1 more
Feb 23, 2022
Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)
Recruiting
- Renal Cell Carcinoma
- +3 more
- Arterial Doppler for Flow Mediated Reserve measurement
-
Paris, FranceINstitut Mutualiste Montsouris
Aug 29, 2023
Vaccine Response Impaired Trial in Adelaide (BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule)
Recruiting
- Vaccine Response Impaired
- BCG vaccine
- +3 more
-
Adelaide, South Australia, AustraliaSouth Australian Health and Medical Research Institute
Nov 17, 2023
COVID-19 Vaccine Responses in PIDD Subjects
Recruiting
- X-linked Agammaglobulinemia
- +6 more
-
Saint Petersburg, Florida
- +2 more
Apr 7, 2022
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder Trial in Wuhan (CT103A
Recruiting
- Autoimmune Diseases
- +5 more
- CT103A cells
- Cyclophosphamide and fludarabine
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Dec 10, 2022
Antibody-mediated Rejection, NMO Spectrum Disorder, TTP Trial in Iowa City
Recruiting
- Antibody-mediated Rejection
- +3 more
-
Iowa City, IowaDeGowin blood Center
Oct 31, 2022
ddcfDNA in Kidney Transplant Recipients
Recruiting
- Kidney Transplant Rejection
- AlloSeq cfDNA
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 22, 2023
Donor-Derived Cell-Free DNA With Tocilizumab Treatment for
Active, not recruiting
- Rejection Chronic Renal
- Kidney Transplant Rejection
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 18, 2022
Mumps, Measles, Rubella Trial in Zürich (MMR booster vaccination (as M-M-R-VaxPro))
Not yet recruiting
- Mumps
- +2 more
- MMR booster vaccination (as M-M-R-VaxPro)
-
Zürich, SwitzerlandEpidemiology, Biostatistics and Prevention Institute University
Jun 8, 2023
Immune Responses to COVID-19 Infection or Vaccination
Recruiting
- COVID-19
- Laboratory assessment of antibody profiles
-
Richmond, VirginiaAditxt
May 17, 2022
Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura
- Caplacizumab
- +2 more
- (no location specified)
Aug 8, 2022
Anti-COVID-19 Humoral and Memory T Cell Responses in Various
Active, not recruiting
- Immune Response
- blood collection
-
Paris, FranceHôpital Robert Debré
Sep 15, 2022
Efficacy of PD-1 Monoclonal Antibody
Recruiting
- Esophageal Squamous Cell Carcinoma
- PD-1 Inhibitor
-
Guangzhou, ChinaNanfang Hospital
Jul 5, 2022
FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at
Recruiting
- Monkeypox
-
Antwerp, BelgiumInstitute of Tropical Medicine
May 19, 2023
Lyme Disease, Borrelia Infections Trial in Zürich (venous blood puncture)
Not yet recruiting
- Lyme Disease
- Borrelia Infections
- venous blood puncture
-
Zürich, SwitzerlandChidren's Hospital Zurich
Sep 13, 2023
Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])
Not yet recruiting
- Acute Myeloid Leukemia
- NK cells
- Talazoparib 1 MG [Talzenna]
- (no location specified)
Jan 9, 2023